HAb18G/CD147 cell-cell contacts confer resistance of a HEK293 subpopulation to anoikis in an E-cadherin-dependent manner.
BACKGROUND
Acquisition of resistance to "anoikis" facilitates the survival of cells under independent matrix-deficient conditions, such as cells in tumor progression and the production of suspension culture cells for biomedical engineering. There is evidence suggesting that CD147, an adhesion molecule associated with survival of cells in tumor metastasis and cell-cell contacts, plays an important role in resistance to anoikis. However, information regarding the functions of CD147 in mediating cell-cell contacts and anoikis-resistance remains limited and even self-contradictory.


RESULTS
An anoikis-resistant clone (HEK293ar), derived from anoikis-sensitive parental Human Embryonic Kidney 293 cells, survived anoikis by the formation of cell-cell contacts. The expression of HAb18G/CD147 (a member of the CD147 family) was upregulated and the protein was located at cell-cell junctions. Upregulation of HAb18G/CD147 in suspended HEK293ar cells suppressed anoikis by mediating the formation of cell-cell adhesions. Anoikis resistance in HEK293ar cells also required E-cadherin-mediated cell-cell contacts. Knock-down of HAb18G/CD147 and E-cadherin inhibited cell-cell contacts formation and increased anoikis sensitivity respectively. When HAb18G/CD147 was downregulated, E-cadherin expression in HEK293ar cells was significantly suppressed; however, knockdown of E-cadherin by E-cadherin siRNA or blocking of E-cadherin binding activity with a specific antibody and EDTA had no significant effect on HAb18G/CD147 expression. Finally, pretreatment with LY294002, a phosphoinositide 3-kinase (PI3K/AKT) inhibitor, disrupted cell-cell contacts and decreased cell number, but this was not the case in cells treated with the extracellular signal-regulated kinase (ERK) inhibitor PD98059.


CONCLUSIONS
Our results provide new evidence that HAb18G/CD147-mediated cell-cell contact confers anoikis resistance in an E-cadherin-dependent manner; and cell-cell contact mediated resistance to anoikis implicates PI3K pathway in a highly relevant cell model (HEK293ar). Understanding of the role of HAb18G/CD147 cell-cell contacts in anoikis resistance may help in understanding the survival of cells in anchorage-independent growth, such as cells in tumor metastasis and suspension culture produced for biomedical engineering. Our results also contribute to a better understanding of the biology of HEK293 cell spheroids, a major workhorse for producing human therapeutic agents and viral vaccines.
Ma
Xiao-Kui
XK
Wang
Li
L
Li
Yu
Y
Yang
Xiang-Ming
XM
Zhao
Pu
P
HaoTang
Zhu
Ping
P
Li
Ling
L
Chen
Zhi-Nan
ZN
D023102:Anoikis / Q000187:drug effects / Q000502:physiology*; D051926:Basigin / Q000378:metabolism*; D015820:Cadherins / Q000378:metabolism*; D002448:Cell Adhesion / Q000502:physiology; D002450:Cell Communication; D057809:HEK293 Cells; D006801:Humans; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology
C497886:BSG protein, human; D015820:Cadherins; D051926:Basigin; D019869:Phosphatidylinositol 3-Kinases
J Infect Dis. 2005 Mar 1;191(5):755-60
15688292
J Biol Chem. 2004 Oct 8;279(41):43061-9
15292248
J Biol Chem. 1998 Jul 3;273(27):16953-61
9642258
J Biol Chem. 2006 Apr 7;281(14):9719-27
16443928
Blood. 2001 Jul 15;98(2):374-82
11435306
Immunobiology. 2006;211(3):167-78
16530084
Cancer Lett. 2008 Dec 18;272(2):177-85
18579285
Gastroenterology. 2007 Feb;132(2):587-600
17258732
Biochem Pharmacol. 2008 Dec 1;76(11):1352-64
18708031
J Cell Physiol. 1998 Sep;176(3):648-57
9699518
Immunology. 1999 Feb;96(2):184-92
10233694
Biochem Biophys Res Commun. 1996 Dec 4;229(1):280-6
8954119
Proc Natl Acad Sci U S A. 1978 Jun;75(6):2805-9
275850
Oral Oncol. 2007 May;43(5):440-54
16978912
Oncogene. 2009 Mar 5;28(9):1206-17
19151754
Cell Mol Life Sci. 2008 Sep;65(18):2933-42
18695939
Apoptosis. 2002 Jun;7(3):247-60
11997669
Am J Physiol Renal Physiol. 2000 May;278(5):F758-68
10807587
Int J Biochem Cell Biol. 2006;38(11):1939-45
16824781
Mol Cancer Res. 2007 Jun;5(6):605-14
17579119
Exp Biol Med (Maywood). 2007 Mar;232(3):344-52
17327467
Cancer Res. 2005 Oct 1;65(19):8836-45
16204054
Cancer Res. 2007 Apr 1;67(7):3094-105
17409416
Methods Cell Biol. 2001;64:211-33
11070841
Cancer Res. 2004 Feb 15;64(4):1229-32
14983875
J Biol Chem. 2004 Mar 19;279(12):11112-8
14707126
Am J Pathol. 2001 Jun;158(6):1921-8
11395366
Biol Reprod. 2001 Apr;64(4):1183-90
11259266
J Biol Chem. 2002 Sep 6;277(36):32905-14
12095980